global medical technology ltd
global medical technology ltd Company Information
Company Number
06043851
Registered Address
42 wright lane, kesgrave, ipswich, IP5 2FA
Industry
Other human health activities
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
abdel rahman ahmed omer 50%
tayseer falaki mustafa 50%
global medical technology ltd Estimated Valuation
Pomanda estimates the enterprise value of GLOBAL MEDICAL TECHNOLOGY LTD at £670.2k based on a Turnover of £2m and 0.34x industry multiple (adjusted for size and gross margin).
global medical technology ltd Estimated Valuation
Pomanda estimates the enterprise value of GLOBAL MEDICAL TECHNOLOGY LTD at £0 based on an EBITDA of £-150 and a 3.1x industry multiple (adjusted for size and gross margin).
global medical technology ltd Estimated Valuation
Pomanda estimates the enterprise value of GLOBAL MEDICAL TECHNOLOGY LTD at £565.6k based on Net Assets of £243.6k and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Global Medical Technology Ltd Overview
Global Medical Technology Ltd is a live company located in ipswich, IP5 2FA with a Companies House number of 06043851. It operates in the other human health activities sector, SIC Code 86900. Founded in January 2007, it's largest shareholder is abdel rahman ahmed omer with a 50% stake. Global Medical Technology Ltd is a established, small sized company, Pomanda has estimated its turnover at £2m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Global Medical Technology Ltd Health Check
Pomanda's financial health check has awarded Global Medical Technology Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
4 Weak
Size
annual sales of £2m, make it larger than the average company (£720.8k)
- Global Medical Technology Ltd
£720.8k - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (5.3%)
- Global Medical Technology Ltd
5.3% - Industry AVG
Production
with a gross margin of 20.5%, this company has a higher cost of product (35.9%)
- Global Medical Technology Ltd
35.9% - Industry AVG
Profitability
an operating margin of 0% make it less profitable than the average company (6%)
- Global Medical Technology Ltd
6% - Industry AVG
Employees
with 27 employees, this is above the industry average (19)
- Global Medical Technology Ltd
19 - Industry AVG
Pay Structure
on an average salary of £24.6k, the company has an equivalent pay structure (£24.6k)
- Global Medical Technology Ltd
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £73.5k, this is more efficient (£43.2k)
- Global Medical Technology Ltd
£43.2k - Industry AVG
Debtor Days
it gets paid by customers after 44 days, this is later than average (22 days)
- Global Medical Technology Ltd
22 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Global Medical Technology Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Global Medical Technology Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Global Medical Technology Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.1%, this is a lower level of debt than the average (21.7%)
0.1% - Global Medical Technology Ltd
21.7% - Industry AVG
GLOBAL MEDICAL TECHNOLOGY LTD financials
Global Medical Technology Ltd's latest turnover from March 2023 is estimated at £2 million and the company has net assets of £243.6 thousand. According to their latest financial statements, we estimate that Global Medical Technology Ltd has 27 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | 0 | |||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | 0 | |||||||||||||
| Profit After Tax | 0 | |||||||||||||
| Dividends Paid | 0 | |||||||||||||
| Retained Profit | 0 | |||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | ||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,213 | 2,426 | 3,639 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,213 | 2,426 | 3,639 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 243,727 | 243,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,877 | 220,000 | 220,000 | 227,148 | 234,522 | 9,588 | 6,453 | 4,596 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24,877 | 27,631 | 25,130 | 7,189 | 217,902 | 184,144 | 116,568 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 243,727 | 243,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,877 | 247,631 | 252,278 | 241,711 | 227,490 | 190,597 | 121,164 |
| total assets | 243,727 | 243,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,877 | 247,631 | 252,278 | 242,924 | 229,916 | 194,236 | 121,164 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 1,000 | 0 | 0 | 0 | 0 | 0 | 2,658 | 7,939 | 16,328 | 26,573 | 33,328 | 9,856 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 1,000 | 0 | 0 | 0 | 0 | 0 | 2,658 | 7,939 | 16,328 | 26,573 | 33,328 | 9,856 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 150 | 150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 150 | 150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 150 | 150 | 1,000 | 0 | 0 | 0 | 0 | 0 | 2,658 | 7,939 | 16,328 | 26,573 | 33,328 | 9,856 |
| net assets | 243,577 | 243,727 | 243,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,973 | 244,339 | 226,596 | 203,343 | 160,908 | 111,308 |
| total shareholders funds | 243,577 | 243,727 | 243,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,877 | 244,973 | 244,339 | 226,596 | 203,343 | 160,908 | 111,308 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,213 | 1,213 | 1,213 | 1,213 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -150 | -1,000 | 0 | 0 | 0 | 0 | 24,877 | 0 | -7,148 | -7,374 | 224,934 | 3,135 | 1,857 | 4,596 |
| Creditors | 0 | -1,000 | 1,000 | 0 | 0 | 0 | 0 | -2,658 | -5,281 | -8,389 | -10,245 | -6,755 | 23,472 | 9,856 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | -24,877 | -2,754 | 2,501 | 17,941 | -210,713 | 33,758 | 67,576 | 116,568 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -24,877 | -2,754 | 2,501 | 17,941 | -210,713 | 33,758 | 67,576 | 116,568 |
global medical technology ltd Credit Report and Business Information
Global Medical Technology Ltd Competitor Analysis
Perform a competitor analysis for global medical technology ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.
global medical technology ltd Ownership
GLOBAL MEDICAL TECHNOLOGY LTD group structure
Global Medical Technology Ltd has no subsidiary companies.
Ultimate parent company
GLOBAL MEDICAL TECHNOLOGY LTD
06043851
global medical technology ltd directors
Global Medical Technology Ltd currently has 2 directors. The longest serving directors include Dr Abdel Omer (Jan 2007) and Ms Tayseer Mustafa (Jul 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Abdel Omer | England | 59 years | Jan 2007 | - | Director |
| Ms Tayseer Mustafa | 59 years | Jul 2023 | - | Director |
P&L
March 2023turnover
2m
+2%
operating profit
-150
0%
gross margin
20.6%
+0.71%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
243.6k
0%
total assets
243.7k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
global medical technology ltd company details
company number
06043851
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
January 2007
age
17
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
42 wright lane, kesgrave, ipswich, IP5 2FA
last accounts submitted
March 2023
global medical technology ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to global medical technology ltd.
global medical technology ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
